These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18977812)

  • 41. Epilepsy and pregnancy.
    Oguni M; Osawa M
    Epilepsia; 2004; 45 Suppl 8():37-41. PubMed ID: 15610193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Supplementation with folic acid before and during pregnancy].
    Saussele T
    Med Monatsschr Pharm; 2008 Dec; 31(12):469-72. PubMed ID: 19133595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A population-based case-control teratologic study of oral oxytetracycline treatment during pregnancy.
    Czeizel AE; Rockenbauer M
    Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):27-33. PubMed ID: 10659913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Awareness of the use of folic acid to prevent neural tube defects in a Mediterranean area.
    Coll O; Pisa S; Palacio M; Quintó L; Cararach V
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):173-7. PubMed ID: 15262351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High dose folic acid supplementation in women with epilepsy: are we sure it is safe?
    Asadi-Pooya AA
    Seizure; 2015 Apr; 27():51-3. PubMed ID: 25891927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maternal drug use and infant cleft lip/palate with special reference to corticoids.
    Källén B
    Cleft Palate Craniofac J; 2003 Nov; 40(6):624-8. PubMed ID: 14577813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maternal body mass index and the association between folic acid supplements and neural tube defects.
    Wang M; Wang ZP; Gao LJ; Gong R; Sun XH; Zhao ZT
    Acta Paediatr; 2013 Sep; 102(9):908-13. PubMed ID: 23750819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Folate and neural tube defects. Recommendations from a Danish working group.
    Rasmussen LB; Andersen NL; Andersson G; Lange AP; Rasmussen K; Skak-Iversen L; Skovby F; Ovesen L
    Dan Med Bull; 1998 Apr; 45(2):213-7. PubMed ID: 9587705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Annual trends in use of periconceptional folic acid and birth prevalence of major congenital malformations.
    Richard-Tremblay AA; Sheehy O; Bérard A
    Curr Drug Saf; 2013 Jul; 8(3):153-61. PubMed ID: 23845112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pregnancy outcome in women exposed to antiepileptic drugs: teratogenic role of maternal epilepsy and its pharmacologic treatment.
    Cassina M; Dilaghi A; Di Gianantonio E; Cesari E; De Santis M; Mannaioni G; Pistelli A; Clementi M
    Reprod Toxicol; 2013 Aug; 39():50-7. PubMed ID: 23591043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pregnancy and birth in women with epilepsy].
    Taubøll E; Gjerstad L; Henriksen T; Husby H
    Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1695-7. PubMed ID: 12821994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment.
    Botto LD; Lisi A; Bower C; Canfield MA; Dattani N; De Vigan C; De Walle H; Erickson DJ; Halliday J; Irgens LM; Lowry RB; McDonnell R; Metneki J; Poetzsch S; Ritvanen A; Robert-Gnansia E; Siffel C; Stoll C; Mastroiacovo P
    Birth Defects Res A Clin Mol Teratol; 2006 Oct; 76(10):693-705. PubMed ID: 17029289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma vitamin values and antiepileptic therapy: case reports of pregnancy outcomes affected by a neural tube defect.
    Candito M; Naimi M; Boisson C; Rudigoz JC; Gaucherand P; Guéant JL; Luton D; Van Obberghen E
    Birth Defects Res A Clin Mol Teratol; 2007 Jan; 79(1):62-4. PubMed ID: 17120234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy.
    Cavalli P; Tonni G; Grosso E; Poggiani C
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):962-5. PubMed ID: 21956977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitamin supply in pregnancy for prevention of congenital birth defects.
    Czeizel AE; Bánhidy F
    Curr Opin Clin Nutr Metab Care; 2011 May; 14(3):291-6. PubMed ID: 21378556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities.
    Czeizel AE; Dobó M; Vargha P
    Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):853-61. PubMed ID: 15523663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of open neural tube defects in Nova Scotia after folic acid fortification.
    Persad VL; Van den Hof MC; Dubé JM; Zimmer P
    CMAJ; 2002 Aug; 167(3):241-5. PubMed ID: 12186168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levetiracetam Pregnancy Registry: Final results and a review of the impact of registry methodology and definitions on the prevalence of major congenital malformations.
    Scheuerle AE; Holmes LB; Albano JD; Badalamenti V; Battino D; Covington D; Harden C; Miller D; Montouris GD; Pantaleoni C; Thorp J; Tofighy A; Tomson T; Golembesky AK
    Birth Defects Res; 2019 Aug; 111(13):872-887. PubMed ID: 31124321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A decreasing rate of neural tube defects following the recommendations for periconceptional folic acid supplementation.
    Klusmann A; Heinrich B; Stöpler H; Gärtner J; Mayatepek E; Von Kries R
    Acta Paediatr; 2005 Nov; 94(11):1538-42. PubMed ID: 16303691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of medical care of epileptic pregnant women based on the rate of congenital abnormalities in their offspring.
    Bánhidy F; Puhó EH; Czeizel AE
    Congenit Anom (Kyoto); 2011 Mar; 51(1):34-42. PubMed ID: 21039911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.